Search

everythinglearnresearchcommunity

for

Search:↓

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Finasteride safely lowers DHT levels without affecting testosterone.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Early balding men may have insulin resistance, but lifestyle changes can help.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Policemen have more hair loss due to obesity, sunlight exposure, and stress.

Higher vitamin D levels are linked to higher iron levels in Korean women without metabolic syndrome, but not in those with it.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.